Results 141 to 150 of about 75,632 (172)

Inhibitory efficacy and structural insights of Bofutrelvir against SARS-CoV-2 M^pro mutants and MERS-CoV M^pro. [PDF]

Commun Biol
Wang W, Zhou X, Li W, Zeng P, Guo L, Wang Q, Li J.   +6 more
europepmc   +1 more source

Modulatory Effects of the Recombinant Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike S1 Subunit Protein on the Phenotype of Camel Monocyte-Derived Macrophages. [PDF]

Biology (Basel)
Hussen J, Al-Mubarak AIA, Shawaf T, Bukhari K, Alkharsah KR.   +4 more
europepmc   +1 more source

MERS-CoV Infection and Its Impact on the Expression of TSLP Cytokine and IgG Antibodies: An In Vivo and In Vitro Study. [PDF]

Infect Drug Resist
Mubarak A, Alqoufail M, Almutairi S, Alrfaei B, Almotairi A, Aziz I, Almanaa TN, Abdel-Maksoud MA, Farrag MA, Aldreiwish AD, Awadalla ME, Alosaimi B, Alturaiki W.   +12 more
europepmc   +1 more source

The time between symptom onset and various clinical outcomes: a statistical analysis of MERS-CoV patients in Saudi Arabia. [PDF]

R Soc Open Sci
Althobaity YM, Alkhudaydi MH, Hill EM, Thompson RN, Tildesley MJ.   +4 more
europepmc   +1 more source

Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells. [PDF]

J Virol
Hoffmann M, Kleine-Weber H, Graichen L, Nehlmeier I, Kempf A, Moldenhauer A-S, Braun E, Assiri AM, Kirchhoff F, Sauter D, Alkharsah KR, Pöhlmann S.   +11 more
europepmc   +1 more source

Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings. [PDF]

Viruses
Karani A, Ombok C, Situma S, Breiman R, Mureithi M, Jaoko W, Njenga MK, Ngere I.   +7 more
europepmc   +1 more source

Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo. [PDF]

Vaccines (Basel)
Zhang Y, Tian C, Yu X, Yu G, Han X, Wang Y, Zhou H, Zhang S, Li M, Yang T, Sun Y, Tai W, Yin Q, Zhao G.   +13 more
europepmc   +1 more source

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies. [PDF]

iScience
Abiona OM, Wang N, Leist SR, Schäfer A, Cockrell AS, Wang L, Bangaru S, Stevens L, Graham RL, Kocher JF, Tsybovsky Y, Kanekiyo M, Kumar A, Morabito KM, Rosen O, Shi W, Werner A, Zhang Y, Ziwawo C, Dzuvor CKO, Palandjian C, Eastman C, Matthews HR, Joseph J, Chappell JD, Kong WP, Mascola JR, Ward AB, Denison MR, Baric R, McLellan JS, Graham BS, Corbett-Helaire KS.   +32 more
europepmc   +1 more source

Correction: Fan et al. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV. <i>Viruses</i> 2018, <i>10</i>, 448. [PDF]

Viruses
Fan C, Wu X, Liu Q, Li Q, Liu S, Lu J, Yang Y, Cao Y, Huang W, Liang C, Ying T, Jiang S, Wang Y.   +12 more
europepmc   +1 more source